Park, Jin-Sil <br/><br/>
TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.  [electronic resource] 

 -  Cytokine  Oct 2012 
 - 143-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2012.06.285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arthritis, Experimental--genetics<br/>Arthritis, Rheumatoid--blood<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Cells, Cultured<br/>Cytokine TWEAK<br/>Drug Synergism<br/>Enzyme-Linked Immunosorbent Assay<br/>Gene Expression--drug effects<br/>Interleukin-17--blood<br/>Interleukin-23--pharmacology<br/>Interleukins--pharmacology<br/>Lipopolysaccharides--pharmacology<br/>Male<br/>Mice<br/>Mice, Inbred DBA<br/>Osteoarthritis--blood<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Recombinant Proteins--pharmacology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Spleen--cytology<br/>TWEAK Receptor<br/>Tumor Necrosis Factors--blood<br/>Interleukin-21